Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (431-440 of 461) with videos related to

Pageof 47
Sort By:
Neuropsychopharmacology Reports|December 22, 2025
Evaluation of GABAergic and Glutamatergic Levels in the Dorsal Anterior Cingulate Cortex of Patients With Bipolar Disorder: A Cross-Sectional <sup>1</sup>H-MRS StudySotaro Moriyama, Yoshihiro Noda, Shiori Honda, et al.
Brain Stimulation|December 26, 2024
Effectiveness of sequential bilateral repetitive transcranial stimulation versus bilateral theta burst stimulation for patients with treatment-resistant depression (BEAT-D): A randomized non-inferiority clinical trialMasataka Wada, Shinichiro Nakajima, Keita Taniguchi, et al.
Schizophrenia Research|January 15, 2023
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophreniaKamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Translational Psychiatry|October 2, 2024
Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorderYasunori Sano, Yasuharu Yamamoto, Manabu Kubota, et al.
Pathology, Research and Practice|October 2, 2024
All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of gliomaNayuta Higa, Toshiaki Akahane, Mari Kirishima, et al.
Brain Imaging and Behavior|November 2, 2023
Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medicationHideaki Tani, Iska Moxon-Emre, Natalie J Forde, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophreniaRyosuke Tarumi, Shiori Honda, Clifford Cassidy, et al.
BMC Psychiatry|November 19, 2013
Melancholic and reactive depression: a reappraisal of old categoriesJin Mizushima, Hitoshi Sakurai, Yuya Mizuno, et al.
Pharmacopsychiatry|July 7, 2026
Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled TrialKie Nomoto, Yohei Ohtani, Taisuke Yatomi, et al.
Psychiatry and Clinical Neurosciences|August 30, 2024
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trialYohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, et al.
Pageof 47

Showing results (431-440 of 461) with videos related to

Sort By:
Pageof 47
Neuropsychopharmacology Reports|December 22, 2025
Evaluation of GABAergic and Glutamatergic Levels in the Dorsal Anterior Cingulate Cortex of Patients With Bipolar Disorder: A Cross-Sectional <sup>1</sup>H-MRS StudySotaro Moriyama, Yoshihiro Noda, Shiori Honda, et al.
Brain Stimulation|December 26, 2024
Effectiveness of sequential bilateral repetitive transcranial stimulation versus bilateral theta burst stimulation for patients with treatment-resistant depression (BEAT-D): A randomized non-inferiority clinical trialMasataka Wada, Shinichiro Nakajima, Keita Taniguchi, et al.
Schizophrenia Research|January 15, 2023
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophreniaKamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Translational Psychiatry|October 2, 2024
Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorderYasunori Sano, Yasuharu Yamamoto, Manabu Kubota, et al.
Pathology, Research and Practice|October 2, 2024
All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of gliomaNayuta Higa, Toshiaki Akahane, Mari Kirishima, et al.
Brain Imaging and Behavior|November 2, 2023
Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medicationHideaki Tani, Iska Moxon-Emre, Natalie J Forde, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophreniaRyosuke Tarumi, Shiori Honda, Clifford Cassidy, et al.
BMC Psychiatry|November 19, 2013
Melancholic and reactive depression: a reappraisal of old categoriesJin Mizushima, Hitoshi Sakurai, Yuya Mizuno, et al.
Pharmacopsychiatry|July 7, 2026
Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled TrialKie Nomoto, Yohei Ohtani, Taisuke Yatomi, et al.
Psychiatry and Clinical Neurosciences|August 30, 2024
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trialYohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, et al.
Pageof 47